Red Door Communications wins Aventis Pasteur remit

Red Door Communications has been hired by Aventis Pasteur MSD to

restore confidence in the controversial MMR vaccine among health

workers.



Aventis has appointed Red Door to handle its travel and child vaccine

portfolios, which includes the under-fire vaccine, used to counter

mumps, measles and rubella.



MMR vaccine has been linked with bowel disorders and autism by experts

at London's Royal Free Hospital.



Red Door replaces incumbent of two years, Grayling Group, following a

two-way pitch. Grayling, which did not re-pitch, will continue to handle

Aventis's corporate account and Hepatitis B portfolio.



A six-strong team, headed by Red Door MD Catherine Warne, will handle

the account, reporting to the vaccine's project managers and Aventis

marketing director Jane Alexander.



Warne said: 'There's a big job to do with the healthcare professionals

regarding MMR.'



In January the Department of Health announced it would co-ordinate a

pounds 3m campaign aimed at restoring confidence in the vaccine among

parents.



Aventis communications manager Amanda Bryett said: 'The Department of

Health is directing the campaign from the consumer side. Red Door will

target practice nurses and GPs - those who are in contact with the

parents.'



Aventis's child vaccine portfolio also includes the DTP/Hib vaccine for

diphtheria, tetanus, polio and haemophilus.



Work to be carried out for the travel vaccine portfolio is aimed at

healthcare workers, but also includes a consumer educational programme

to promote the importance of getting vaccinated before travelling to

certain destinations.



The agency will also work on the company's pneumovax II vaccine for

pneumococcal pneumonia.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in